Atıf Formatları
Subcutaneous nodules as a clinical biomarker of Farber disease
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

J. Mitchell Et Al. , "Subcutaneous nodules as a clinical biomarker of Farber disease," MOLECULAR GENETICS AND METABOLISM , vol.135, no.2, 2022

Mitchell, J. Et Al. 2022. Subcutaneous nodules as a clinical biomarker of Farber disease. MOLECULAR GENETICS AND METABOLISM , vol.135, no.2 .

Mitchell, J., Harmatz, P., Selim, L., El Din, I. G., Mungan, N., Bulut, F., ... Lampe, C.(2022). Subcutaneous nodules as a clinical biomarker of Farber disease. MOLECULAR GENETICS AND METABOLISM , vol.135, no.2.

Mitchell, John Et Al. "Subcutaneous nodules as a clinical biomarker of Farber disease," MOLECULAR GENETICS AND METABOLISM , vol.135, no.2, 2022

Mitchell, John Et Al. "Subcutaneous nodules as a clinical biomarker of Farber disease." MOLECULAR GENETICS AND METABOLISM , vol.135, no.2, 2022

Mitchell, J. Et Al. (2022) . "Subcutaneous nodules as a clinical biomarker of Farber disease." MOLECULAR GENETICS AND METABOLISM , vol.135, no.2.

@article{article, author={John Mitchell Et Al. }, title={Subcutaneous nodules as a clinical biomarker of Farber disease}, journal={MOLECULAR GENETICS AND METABOLISM}, year=2022}